However, PTBP1 inhibitors are still in a vacant state in gastric cancer treatment, and our results confirm that PTBP1 is critical to the progression of gastric cancer, therefore PTBP1 inhibitors suitable for gastric cancer targets are urgently exploited. This evidence concerns the gene PTBP1 and gastric cancer.